Promotion by the British pharmaceutical industry, 1983-8: a critical analysis of self regulation.
نویسندگان
چکیده
Since 1958 the Association of the British Pharmaceutical Industry (ABPI) has attempted to regulate the promotion of prescription medicines through its code of practice. This regulation is described and analysed for the six years 1983-8 using the reports on 302 complaints considered by its code of practice committee and annual reports. The complaints came mainly from doctors (143, 48%) and competing companies (103, 33%). The committee found a total of 379 breaches of the code in 192 (63%) of the complaints. Additional breaches were detected by informational scrutiny of advertisements by the ABPI secretariat. Analysis showed that 270 (71%) of these breaches involved possible breaches of the Medicines Act. The rules that forbid misleading or unsubstantiated information and misleading claims or comparisons were broken most often. The committee found the most frequent offenders to be Organon (32 breaches), Smith Kline and French (23), Glaxo (21), A H Robins (18), Bayer (17), Merck Sharp and Dohme (17), and Lederle (16). Often the promotion of one product led to several breaches. The promotional wars over histamine H2 receptor antagonists accounted for 33 breaches. It is estimated that in 1983-8 about 100 breaches of the code were detected a year. In the 18 years 1972-88 the Medicines Act was breached probably over 1200 times. Health ministers, by not enforcing the regulations controlling promotion, have abrogated their responsibility to the ABPI, but the evidence suggests that the code has failed to deter promotional excesses. The ABPI's wish to secure compliance with the code seems weaker than its wish to pre-empt outside criticism and action: its self regulation seems to be a service to itself rather than to the public. It is suggested that the code of practice committee should become publicly accountable, that the majority of its members should represent the health professions and the public, and that effective sanctions are needed.
منابع مشابه
A Dynamic Model for Promotion of Iranian Pharmaceutical and Biological Enterprises
The purpose of this paper is to make explicit how companies in pharmaceutical sector can ensure their position in different markets by relying on a sustainable competitive advantages resulted from using a good defined marketing model. Various factors are highlighted including high research and development roles and costs, hard government regulation in frame of GMP standard, market analysis to...
متن کاملThe Representation of Iran’s Nuclear Program in British Newspaper Editorials: A Critical Discourse Analytic Perspective
In this study, Van Dijk’s (1998) model of CDA was utilized in order to examine the representation of Iran’s nuclear program in editorials published by British news casting companies. The analysis of the editorials was carried out at two levels of headlines and full text stories with regard to the linguistic features of lexical choices, nominalization, passivization, overcompleteness, and voice....
متن کاملرابطه سواد اطلاعاتی و تفکر انتقادی با راهبردهای خود تنظیمی دانشجویان پرستاری
Introduction: Improving self-regulation strategies is one of the most important purposes in medical education in the century of information. This study aims to investigate relationship between critical thinking and information literacy with self-regulation strategies of Nursing School at Razi Medical Science University in the academic year of 2014-2015. Materials and Methods: This stud...
متن کاملساختار عاملی و اعتباریابی نسخه فارسی پرسشنامه خودنظم دهی در بین دانشجویان پزشکی
Introduction: self-regulation is an important construct in motivation through which the students regulate their learning meta-cognition. Self-regulation is one of the most important predictive factors of academic achievement. Therefore evaluating academic self-regulation in learners is critical. The aim of this study was to develop validity and to determine the factors structure a self-regulati...
متن کاملComplaints, Complainants, and Rulings Regarding Drug Promotion in the United Kingdom and Sweden 2004–2012: A Quantitative and Qualitative Study of Pharmaceutical Industry Self-Regulation
BACKGROUND In many European countries, medicines promotion is governed by voluntary codes of practice administered by the pharmaceutical industry under its own system of self-regulation. Involvement of industry organizations in policing promotion has been proposed to deter illicit conduct, but few detailed studies on self-regulation have been carried out to date. The objective of this study was...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- BMJ
دوره 300 6720 شماره
صفحات -
تاریخ انتشار 1990